Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: Technique and early results

Clinical Lung Cancer

Volumn 13, Issue 5, 2012, Pages 352-358

  Hoppe, Bradford S ^a,b   Flampouri, Stella ^a,b   Henderson, Randal H ^a,b   Pham, Dat ^a   Bajwa, Abubakr A ^a   D'Agostino, Harry ^a   Huh, Soon N ^a,b   Li, Zuofeng ^a,b   Mendenhall, Nancy P ^a,b   Nichols, R Charles ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Concurrent chemotherapy; Dose distribution; Lung cancer; Outcomes; Radiation therapy

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER RELAPSE; CANCER STAGING; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; DYSPNEA; ESOPHAGITIS; FATIGUE; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; INDUCTION CHEMOTHERAPY; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PROTON THERAPY; RADIATION DOSE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; COMPUTER SIMULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PROTON THERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84863203606     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.11.008     Document Type: Article

References (31)

1. A. Jemal, R. Siegel, J. Xu Cancer statistics, 2010 CA: Cancer J Clin 60 2010 277 300
2. A. Auperin, C. Le Pechoux, E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
3. K. Furuse, M. Fukuoka, M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
4. M.V. Graham, J.A. Purdy, B. Emami Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 1999 323 329
5. F.R. Macbeth, T.E. Wheldon, D.J. Girling Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer The Medical Research Council Lung Cancer Working Party Clin Oncol 8 1996 176 181
6. Z.C. Zhang, J. Xu, B.S. Li Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer Am J Clin Oncol 33 2010 271 275
7. J.G. Rosenman, J.S. Halle, M.A. Socinski High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial Int J Radiat Oncol Biol Phys 54 2002 348 356
8. R. Rengan, K.E. Rosenzweig, E. Venkatraman Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 60 2004 741 747
9. T. Auberger, K. Seydl, T. Futschek Photons or protons: precision radiotherapy of lung cancer Strahlenther Onkol 183 2007 3 6 Spec No 2
10. R.C. Nichols, S.N. Huh, R.H. Henderson Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage III non-small-cell lung cancer: a dosimetric study Clin Lung Cancer 12 2011 252 257
11. J.Y. Chang, X. Zhang, X. Wang Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 2006 1087 1096
12. J.P. Grutters, A.G. Kessels, M. Pijls-Johannesma Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis Radiother Oncol 95 2010 32 40
13. H. Nakayama, S. Sugahara, M. Tokita Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the University of Tsukuba Int J Radiat Oncol Biol Phys 78 2010 467 471
14. H. Iwata, M. Murakami, Y. Demizu High-dose proton therapy and carbon-ion therapy for stage I Non-Small cell lung cancer Cancer 116 2010 2476 2485
15. D.A. Bush, J.D. Slater, B.B. Shin Hypofractionated proton beam radiotherapy for stage I lung cancer Chest 126 2004 1198 1203
16. Y. Shioyama, K. Tokuuye, T. Okumura Clinical evaluation of proton radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 56 2003 7 13
17. S. Sejpal, R. Komaki, A. Tsao Early findings on toxicity of proton beam therapy with concurrent chemotherapy for Non-Small cell lung cancer Cancer 117 2011 3004 3013
18. J.Y. Chang, R. Komaki, H.Y. Wen Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer Int J Radiat Oncol Biol Phys 80 2011 1350 1357
19. R.B. Bonnet, D. Bush, G.A. Cheek Effects of proton and combined proton/photon beam radiation on pulmonary function in patients with resectable but medically inoperable non-small cell lung cancer Chest 120 2001 1803 1810
20. H. Nakayama, H. Satoh, S. Sugahara Proton beam therapy of stage II and III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 81 2011 979 984
21. J.D. Cox, J.Y. Chang, Z. Liao Acute esophageal reactions from proton beam therapy and concurrent chemotherapy for non-small cell lung Cancer (NSCLC): teduction in incidence and severity despite higher doses Int J Radiat Oncol Biol Phys 69 2007 S485
22. H. Nakayama, K. Tokuuye, H. Ishikawa High-dose radiotherapy in patients with stage III non-small cell lung cancer in practical experience Int J Radiat Oncol Biol Phys 69 2007 S522 S523
23. J.Y. Chang, R. Komaki, M.K. Bucci Failure patterns and toxicity of concurrent proton therapy and chemotherapy for stage III Non-Small cell lung cancer Int J Radiat Oncol Biol Phys 75 2009 S446 S447
24. O. Chapet, F.M. Kong, L.E. Quint CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan Int J Radiat Oncol Biol Phys 63 2005 170 178
25. A.R. Yeung, J. Li, W. Shi Optimal image-guidance scenario with cone-beam computed tomography in conventionally fractionated radiotherapy for lung tumors Am J Clin Oncol 33 2010 276 280
26. Y. Kang, X. Zhang, J.Y. Chang 4D proton treatment planning strategy for mobile lung tumors Int J Radiat Oncol Biol Phys 67 2007 906 914
27. M.F. Moyers, D.W. Miller, D.A. Bush Methodologies and tools for proton beam design for lung tumors Int J Radiat Oncol Biol Phys 49 2001 1429 1438
28. J.D. Bradley, K. Bae, M.V. Graham Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117 J Clin Oncol 28 2010 2475 2480
29. J.Y. Chang, R. Komaki, C. Lu Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III Non-Small cell lung cancer Cancer 2011 Mar 22 [Epub ahead of print]
30. Bradley JD, Paulus R, Komaki R, et al. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapyb/- cetuximab for stage IIIA/IIIB non-small cell lung cancer: preliminary findings on radiation dose in RTOG 0617. ASTRO's 53rd Annual Meeting, Oct 2-6 2011. Miami, FL.
31. K.L. Miller, T.D. Shafman, M.S. Anscher Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys 61 2005 64 69